Lyell Immunopharma Stock Target Price and Analyst Consensus

LYEL Stock  USD 0.58  0.02  3.57%   
The current analyst and expert consensus on Lyell Immunopharma is Hold, with no strong buy opinions. The current projected Lyell Immunopharma target price consensus is 0.80 with 4 analyst opinions. Check out Macroaxis Advice on Lyell Immunopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.
The most common way Lyell Immunopharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Lyell Immunopharma executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Lyell Immunopharma. We encourage you to use your own analysis of Lyell Immunopharma to validate this buy or sell advice. Lyell Immunopharma buy-or-sell recommendation module provides average expert sentiment on the projected Lyell Immunopharma target price to derive its highest and lowest estimates based on projected price volatility of 6.6889.
Lowest Forecast
0.73
Highest Forecast
0.89
Target Price
0.8
Gross Profit Margin is expected to rise to 0.76 this year, although the value of Gross Profit will most likely fall to about 142 K. At this time, Lyell Immunopharma's Cash is quite stable compared to the past year. Non Current Assets Total is expected to rise to about 305.5 M this year, although the value of Other Liabilities will most likely fall to about 3.5 M.
  
It's important to approach Lyell Immunopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Lyell Immunopharma price targets

Lyell Immunopharma's stock target price is an estimate of its future price, usually made by analysts. Using Lyell Immunopharma's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Lyell Immunopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Lyell Immunopharma's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Lyell Immunopharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Lyell Immunopharma is a key component of Lyell Immunopharma valuation and have some predictive power on the future returns of a Lyell Immunopharma.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lyell Immunopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.377.06
Details
Intrinsic
Valuation
LowRealHigh
0.030.687.37
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.14-0.14-0.14
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
USD Crypto Fund Idea
USD Crypto Fund
Invested less than 1 share
Macroaxis Index Idea
Macroaxis Index
Invested over 10K shares
Manufacturing Idea
Manufacturing
Invested over 40 shares
Diversified Assets Idea
Diversified Assets
Invested over 40 shares
When determining whether Lyell Immunopharma is a strong investment it is important to analyze Lyell Immunopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lyell Immunopharma's future performance. For an informed investment choice regarding Lyell Stock, refer to the following important reports:
Check out Macroaxis Advice on Lyell Immunopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.